Weight loss decreases risk of breast cancer in susceptible womenAugust 22, 2005Women with a mutation in the gene BRCA1, which predisposes women to breast cancer, are 65% less likely to develop the disease if they lose weight between 18 and 30 years of age. Research published in the open access journal Breast Cancer Research suggests that young women with this genetic predisposition should avoid putting on weight in early adulthood, especially if they plan to have children. Steven Narod from the University of Toronto, Canada, and colleagues from universities in Canada, the USA and Poland studied two groups of women, all of whom had a mutation in one of the breast cancer susceptibility genes BRCA1 and BRCA2. The first group had been diagnosed with breast cancer while the second group had not. Each member of the first group was paired up, or 'matched', with a woman from the second group who was the same age, carried a mutation in the same gene and lived in the same country. This is the largest study of this kind to date, with 1073 women from five different countries in each group. By comparing the two groups, the researchers could identify the relationship between the incidence of breast cancer before the menopause in women at risk, and weight at 18, 30 and 40 years of age. Their results show that, for women who have a mutation in BRCA1, "weight loss of at least 10 pounds was associated with a 65% reduction in cancer risk between ages 30 and 40." The study also shows that BRCA1 mutation carriers who gained 10 pounds or more between 18 and 30 years of age are 44% more at risk of developing breast cancer if they have 2 children or more. No association between weight loss and breast cancer risk was shown in BRCA2 mutation carriers.
BioMed Central | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. New mammography technology effective in detecting breast cancer A study has found that positron emission mammography (PEM), a new technique for imaging the breast, is not affected by either breast density or a woman's hormonal status, two factors that limit the effectiveness of standard mammography and MRI at detecting cancer. New statistical model could help reduce breast-lesion biopsies A new method of characterizing breast lesions found during an MRI exam could result in fewer biopsies of benign tumors with the benefits of reduced pain and expense for patients and providers, according to a paper that will be presented today (Sunday, Nov. 30) at the annual meeting of the Radiological Society of North America (RSNA). Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding A cost-effectiveness analysis conducted by researchers at Stanford University Hospital in Calif., shows that an initial double-balloon enteroscopy (DBE) is a cost-effective approach for patients with obscure gastrointestinal (GI) bleeding. Study identifies causes of bone loss in breast cancer survivors Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||